BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 5380948)

  • 21. [Antiplasmin and its effect on the process of fibrinolysis in experiments].
    Kudriashov BA; Pastorova VE
    Biull Eksp Biol Med; 1966 Feb; 61(2):40-2. PubMed ID: 4235805
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fibrinolytic bleedings in urology].
    Lipsky H; Hubmer O
    Z Urol Nephrol; 1969; 62(6):453-61. PubMed ID: 5314209
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP; Ferguson JH
    Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 25. [Proof of the antifibrinolytic action of the protease inhibitor Contrykal in vivo].
    Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):136-41. PubMed ID: 4174651
    [No Abstract]   [Full Text] [Related]  

  • 26. Clot lysis in a perfusion system.
    Bouvier CA; Gruendlinger J; Berthoud S
    Thromb Diath Haemorrh; 1966 Jan; 15(1):205-19. PubMed ID: 5919801
    [No Abstract]   [Full Text] [Related]  

  • 27. [Animal experimental studies of the effect of synthetic antifibrinolytics].
    Markwardt F; Klöcking HP
    Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery.
    Ambrus JL; Schimert G; Lajos TZ; Ambrus CM; Mink IB; Lassman HB; Moore RH; Melzer J
    J Med; 1971; 2(2):65-81. PubMed ID: 4329735
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the effect of various antifibrinolytic agents on blood coagulation].
    Gerl D; Bonow A
    Med Klin; 1969 Feb; 64(9):374-8. PubMed ID: 5783025
    [No Abstract]   [Full Text] [Related]  

  • 30. Antifibrinolytic action of the anticoagulant split product of fibrinogen.
    Nanninga LB; Guest MM
    Thromb Diath Haemorrh; 1968 Jul; 19(3):526-32. PubMed ID: 5708130
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A; Vermylen J; Verstraete M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):7-19. PubMed ID: 4189377
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

  • 33. [The development of fibrinolysis inhibitors].
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):5-14. PubMed ID: 4173881
    [No Abstract]   [Full Text] [Related]  

  • 34. [p-Aminomethylbenzoic acid (PAMBA), a new antifibrinolytic agent. Experimental animal studies].
    Markwardt F; Klöcking HP
    Munch Med Wochenschr; 1965 Oct; 107(41):2000-2. PubMed ID: 5898921
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
    Veremienko KN; Varetskaia TV; Kizim AI; Gerasimenko NG
    Ukr Biokhim Zh; 1976; 48(3):337-42. PubMed ID: 134480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of action of synthetic fibrinolytic compounds.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):495-506. PubMed ID: 5503944
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of some synthetic compounds on in vitro fibrinolytic activity measured by different methods and the relevance to activity in vivo.
    Baillie AJ; Sim AK
    Thromb Diath Haemorrh; 1972 Dec; 28(3):351-8. PubMed ID: 4265316
    [No Abstract]   [Full Text] [Related]  

  • 40. Fibrinogen degradation products in experimental intravascular coagulation. Gel filtration and immunological studies.
    Zetterqvist E
    Acta Physiol Scand; 1971 Jul; 82(3):289-99. PubMed ID: 4108400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.